USNA Earnings & Financial Statements
USANA Health Sciences, Inc.
$15.27
-$0.19(-1.23%)
54
Overall
70
Value
50
Tech
42
Quality
Market Cap
$285.65M
Volume
236.37K
52W Range
$12.57 - $23.59
Target Price
$25.00
USNA earnings and financial statements: USANA Health Sciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
USNA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $925.26M | $854.50M | $921.01M | $998.60M | $1.19B |
| Cost of revenue | $200.85M | $161.21M | $176.69M | $193.89M | $217.90M |
| Operating income | $37.43M | $66.32M | $93.07M | $107.61M | $170.19M |
| EBITDA | $82.07M | $98.86M | $123.11M | $130.22M | $192.89M |
| Net income | $10.76M | $42.03M | $63.79M | $69.35M | $116.50M |
| EPS (diluted) | $0.58 | $2.19 | $3.30 | $3.59 | $5.73 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $742.91M | $748.19M | $632.76M | $596.55M | $577.74M |
| Total liabilities | $156.64M | $161.86M | $135.56M | $162.08M | $182.62M |
| Shareholders’ equity | $533.10M | $532.11M | $497.20M | $434.47M | $395.12M |
| Cash and equivalents | $158.38M | $181.77M | $330.42M | $288.42M | $239.83M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $22.35M | $60.99M | $70.64M | $103.90M | $121.23M |
| Capital expenditure | -$9.92M | -$10.01M | -$14.49M | -$10.40M | -$12.76M |
| Free cash flow | $8.53M | $50.92M | $56.15M | $93.50M | $108.46M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | USNA | $15.27 | -1.2% | 236.37K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get USANA Health Sciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW